Review
doi: 10.1016/j.jacc.2008.10.008.
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association
Affiliations
- PMID: 19147051
- DOI: 10.1016/j.jacc.2008.10.008
Item in Clipboard
Review
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association
J Am Coll Cardiol.
.
Free article
No abstract available
Similar articles
-
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.Circulation. 2009 Jan 20;119(2):351-7. doi: 10.1161/CIRCULATIONAHA.108.191305. Epub 2008 Dec 17. Circulation. 2009. PMID: 19095622 No abstract available.
-
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association: response to Skyler et al.Diabetes Care. 2009 Jul;32(7):e90-1; author reply e92-3. doi: 10.2337/dc09-9030. Diabetes Care. 2009. PMID: 19564469 No abstract available.
-
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.Diabetes Care. 2009 Jan;32(1):187-92. doi: 10.2337/dc08-9026. Epub 2008 Dec 17. Diabetes Care. 2009. PMID: 19092168 Free PMC article. No abstract available.
-
Implications of intensive glycemic control on cardiovascular disease: early reports from the ACCORD and ADVANCE Trials.Rev Cardiovasc Med. 2008 Winter;9(1):1-4. Rev Cardiovasc Med. 2008. PMID: 18418304 Review. No abstract available.
-
Should you put all diabetic patients on statins?J Fam Pract. 2007 Apr;56(4):294-300. J Fam Pract. 2007. PMID: 17403328 Review. No abstract available.
Cited by
-
The Role of Obesity as a Cardiac Disease Risk Factor in Patients with Type 2 Diabetes.Curr Cardiol Rep. 2024 Nov;26(11):1309-1320. doi: 10.1007/s11886-024-02129-z. Epub 2024 Sep 5. Curr Cardiol Rep. 2024. PMID: 39235729 Review.
-
Diabetes and Stroke: Impact of Novel Therapies for the Treatment of Type 2 Diabetes Mellitus.Biomedicines. 2024 May 16;12(5):1102. doi: 10.3390/biomedicines12051102. Biomedicines. 2024. PMID: 38791064 Free PMC article. Review.
-
Potential Mediators for Treatment Effects of Novel Diabetes Medications on Cardiovascular and Renal Outcomes: A Meta-Regression Analysis.J Am Heart Assoc. 2024 Feb 20;13(4):e032463. doi: 10.1161/JAHA.123.032463. Epub 2024 Feb 16. J Am Heart Assoc. 2024. PMID: 38362889 Free PMC article.
-
Long-term glycemic variability predicts compromised development of heart failure with improved ejection fraction: a cohort study.Front Endocrinol (Lausanne). 2023 Sep 20;14:1211954. doi: 10.3389/fendo.2023.1211954. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37800137 Free PMC article.
-
Working with Convex Responses: Antifragility from Finance to Oncology.Entropy (Basel). 2023 Feb 13;25(2):343. doi: 10.3390/e25020343. Entropy (Basel). 2023. PMID: 36832709 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
